Crystal Structure of the Complex of Human Epidermal Growth Factor and Receptor Extracellular Domains
暂无分享,去创建一个
Jae-Hoon Kim | Kazuki Saito | Shigeyuki Yokoyama | Osamu Nureki | Mikako Shirouzu | Ryuichiro Ishitani | O. Nureki | Kazuki Saito | S. Yokoyama | R. Ishitani | M. Shirouzu | A. Sakamoto | Jae-Hoon Kim | S. Fukai | Shuya Fukai | Ayako Sakamoto | Hideo Ogiso | Mari Yamanaka | Mio Inoue | H. Ogiso | M. Inoue | M. Yamanaka | K. Saito
[1] A. Burgess,et al. Structure-Function relationships for the EGF/TGF-α family of mitogens , 1994 .
[2] S. Takahashi,et al. A site-directed mutagenesis study on the role of isoleucine-23 of human epidermal growth factor in the receptor binding. , 1992, Biochimica et Biophysica Acta.
[3] A. Ullrich,et al. Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences , 1984, Nature.
[4] M. O’Connor-McCourt,et al. The extracellular domain of the epidermal growth factor receptor. Studies on the affinity and stoichiometry of binding, receptor dimerization and a binding-domain mutant. , 1994, European journal of biochemistry.
[5] 龍喜 荒尾,et al. メラノサイト系腫瘍におけるGrowth factor receptorの局在 , 1990 .
[6] Z. Otwinowski,et al. [20] Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.
[7] Waterfield,et al. Analysis of mammalian fibroblast transformation by normal and mutated human EGF receptors. , 1989, Oncogene.
[8] J. Navaza,et al. AMoRe: an automated package for molecular replacement , 1994 .
[9] S. Yokoyama,et al. Recognition of an antiparallel β‐sheet structure of human epidermal growth factor by its receptor Site‐directed mutagenesis studies of Ala‐30 and Asn‐32 , 1992, FEBS letters.
[10] Crystallization and preliminary X-ray crystallographic analysis of the EGF receptor ectodomain. , 1998, Acta crystallographica. Section D, Biological crystallography.
[11] S. Cohen,et al. Epidermal growth factor , 1972, The Journal of investigative dermatology.
[12] J. Zou,et al. Improved methods for building protein models in electron density maps and the location of errors in these models. , 1991, Acta crystallographica. Section A, Foundations of crystallography.
[13] Y. Yarden,et al. A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor , 1996, Molecular and cellular biology.
[14] Toshio Yanagida,et al. Single-molecule imaging of EGFR signalling on the surface of living cells , 2000, Nature Cell Biology.
[15] B. Sykes,et al. NMR study of the differential contributions of residues of transforming growth factor alpha to association with its receptor. , 2000, Protein engineering.
[16] T. Ooi,et al. The erbB gene of avian erythroblastosis virus is a member of the src gene family , 1983, Cell.
[17] L. Hood,et al. Rat transforming growth factor type 1: structure and relation to epidermal growth factor. , 1984, Science.
[18] J. Chai,et al. Crystal Structure of Human Epidermal Growth Factor and Its Dimerization* , 2001, The Journal of Biological Chemistry.
[19] D. Engler,et al. Biochemical properties of site-directed mutants of human epidermal growth factor: importance of solvent-exposed hydrophobic residues of the amino-terminal domain in receptor binding. , 1990, Biochemistry.
[20] Monilola A. Olayioye,et al. The ErbB signaling network: receptor heterodimerization in development and cancer , 2000, The EMBO journal.
[21] Thomas C. Terwilliger,et al. Electronic Reprint Biological Crystallography Maximum-likelihood Density Modification , 2022 .
[22] C. Betzel,et al. The secreted form of the epidermal growth factor receptor. Characterization and crystallization of the receptor-ligand complex. , 1990, The Journal of biological chemistry.
[23] Kazuki Saito,et al. Chimeric receptor analyses of the interactions of the ectodomains of ErbB-1 with epidermal growth factor and of those of ErbB-4 with neuregulin. , 2002, European journal of biochemistry.
[24] C. A. Guyer,et al. Identification of Residues of the Epidermal Growth Factor Receptor Proximal to Residue 45 of Bound Epidermal Growth Factor* , 1996, The Journal of Biological Chemistry.
[25] J. Brugge,et al. Controlled Dimerization of ErbB Receptors Provides Evidence for Differential Signaling by Homo- and Heterodimers , 1999, Molecular and Cellular Biology.
[26] Christian Wiesmann,et al. Crystal structure of nerve growth factor in complex with the ligand-binding domain of the TrkA receptor , 1999, Nature.
[27] J. Stroh,et al. The Structural Basis for the Specificity of Epidermal Growth Factor and Heregulin Binding (*) , 1995, The Journal of Biological Chemistry.
[28] H. Kawasaki,et al. A 40-kDa epidermal growth factor/transforming growth factor alpha-binding domain produced by limited proteolysis of the extracellular domain of the epidermal growth factor receptor. , 1993, The Journal of biological chemistry.
[29] W R Taylor,et al. On the tertiary structure of the extracellular domains of the epidermal growth factor and insulin receptors. , 1987, Biochimica et biophysica acta.
[30] S. Yokoyama,et al. Characterization of the N-oligosaccharides attached to the atypical Asn-X-Cys sequence of recombinant human epidermal growth factor receptor. , 2000, Journal of biochemistry.
[31] R. Jorissen,et al. Identification of a determinant of epidermal growth factor receptor ligand-binding specificity using a truncated, high-affinity form of the ectodomain. , 2001, Biochemistry.
[32] S. Hubbard,et al. Structural Basis for FGF Receptor Dimerization and Activation , 1999, Cell.
[33] C. Ward,et al. Insulin and epidermal growth factor receptors contain the cysteine repeat motif found in the tumor necrosis factor receptor , 1995, Proteins.
[34] D. Kohda,et al. Three-dimensional nuclear magnetic resonance structures of mouse epidermal growth factor in acidic and physiological pH solutions. , 1994, Biochemistry.
[35] I. Lax,et al. Disulfide Bond Structure of Human Epidermal Growth Factor Receptor* , 1998, The Journal of Biological Chemistry.
[36] E. Chen,et al. Human transforming growth factor-α: Precursor structure and expression in E. coli , 1984, Cell.
[37] R J Read,et al. Crystallography & NMR system: A new software suite for macromolecular structure determination. , 1998, Acta crystallographica. Section D, Biological crystallography.
[38] Joseph Schlessinger,et al. Crystal Structures of Two FGF-FGFR Complexes Reveal the Determinants of Ligand-Receptor Specificity , 2000, Cell.
[39] W. Hendrickson,et al. Structural interactions of fibroblast growth factor receptor with its ligands. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[40] D. Engelman,et al. Two EGF molecules contribute additively to stabilization of the EGFR dimer , 1997, The EMBO journal.
[41] L. Wang,et al. Human epidermal growth factor (EGF) receptor sequence recognized by EGF competitive monoclonal antibodies. Evidence for the localization of the EGF-binding site. , 1989, The Journal of biological chemistry.
[42] Robert M. Stroud,et al. Efficiency of signalling through cytokine receptors depends critically on receptor orientation , 1998, Nature.
[43] E C Nice,et al. Stoichiometry, Kinetic and Binding Analysis of the Interaction between Epidermal Growth Factor (EGF) and the Extracellular Domain of the EGF Receptor , 2000, Growth factors.
[44] I. Lax,et al. Ligand-binding enhances the affinity of dimerization of the extracellular domain of the epidermal growth factor receptor. , 1997, Journal of biochemistry.
[45] N. Hynes,et al. ErbB‐2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling , 1997, The EMBO journal.
[46] David F. Burke,et al. Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin , 2000, Nature.
[47] L. Wang,et al. Human epidermal growth factor receptor residue covalently cross-linked to epidermal growth factor. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[48] P. Seeburg,et al. Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells , 1984, Nature.
[49] M. Ultsch,et al. Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. , 1992, Science.
[50] Russ Miller,et al. The design and implementation of SnB version 2.0 , 1999 .
[51] A. Ullrich,et al. Functional analysis of the ligand binding site of EGF‐receptor utilizing chimeric chicken/human receptor molecules. , 1989, The EMBO journal.
[52] J. Schlessinger,et al. Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization. , 2000, Molecular cell.
[53] I. Campbell,et al. The solution structure of human transforming growth factor alpha. , 1993, European journal of biochemistry.
[54] R. Woltjer,et al. Direct identification of residues of the epidermal growth factor receptor in close proximity to the amino terminus of bound epidermal growth factor. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[55] N. Kunishima,et al. Atomic structure of the GCSF–receptor complex showing a new cytokine–receptor recognition scheme , 1999, Nature.
[56] Edouard C. Nice,et al. Crystal Structure of a Truncated Epidermal Growth Factor Receptor Extracellular Domain Bound to Transforming Growth Factor α , 2002, Cell.
[57] H. Wiley,et al. The Enhanced Tumorigenic Activity of a Mutant Epidermal Growth Factor Receptor Common in Human Cancers Is Mediated by Threshold Levels of Constitutive Tyrosine Phosphorylation and Unattenuated Signaling* , 1997, The Journal of Biological Chemistry.
[58] Joseph Schlessinger,et al. Signal transduction by receptors with tyrosine kinase activity , 1990, Cell.
[59] N. Mckern,et al. Crystal structure of the first three domains of the type-1 insulin-like growth factor receptor , 1998, Nature.